357 related articles for article (PubMed ID: 18844621)
1. Crohn's disease but not chronic ulcerative colitis induces the expression of PAI-1 in enteric neurons.
Laerum OD; Illemann M; Skarstein A; Helgeland L; Ovrebø K; Danø K; Nielsen BS
Am J Gastroenterol; 2008 Sep; 103(9):2350-8. PubMed ID: 18844621
[TBL] [Abstract][Full Text] [Related]
2. Fecal radioiodide excretion following intravenous injection of 131-I-albumin and 125-I-immunoglobulin G in chronic inflammatory bowel disease. An aid to topographic diagnosis.
Jarnum S; Jensen KB
Gastroenterology; 1975 Jun; 68(6):1433-44. PubMed ID: 1132626
[TBL] [Abstract][Full Text] [Related]
3. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activators in the intestine of patients with inflammatory bowel disease.
de Bruin PA; Crama-Bohbouth G; Verspaget HW; Verheijen JH; Dooijewaard G; Weterman IT; Lamers CB
Thromb Haemost; 1988 Oct; 60(2):262-6. PubMed ID: 3146142
[TBL] [Abstract][Full Text] [Related]
5. Gastrin releasing peptide receptor expression is decreased in patients with Crohn's disease but not in ulcerative colitis.
ter Beek WP; Muller ES; Van Hogezand RA; Biemond I; Lamers CB
J Clin Pathol; 2004 Oct; 57(10):1047-51. PubMed ID: 15452158
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
7. Axonal degeneration/necrosis: a possible ultrastructural marker for Crohn's disease.
Steinhoff MM; Kodner IJ; DeSchryver-Kecskemeti K
Mod Pathol; 1988 May; 1(3):182-7. PubMed ID: 3237698
[TBL] [Abstract][Full Text] [Related]
8. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
[TBL] [Abstract][Full Text] [Related]
9. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
[TBL] [Abstract][Full Text] [Related]
10. Vascular changes in ulcerative colitis and Leśniowski-Crohn's disease.
Zurawski J; Woźniak A; Salwa-Zurawska W; Kaczmarek E; Majewski P
Pol J Pathol; 2007; 58(1):13-21. PubMed ID: 17585538
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
[TBL] [Abstract][Full Text] [Related]
13. [Inflammatory disease of the gastrointestinal tract at the University Hospital, Medical Center, Puerto Rico. 1980-87].
Moreno JM; Rubio CE; Torres EA
Bol Asoc Med P R; 1989 Jun; 81(6):214-8. PubMed ID: 2765040
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease.
Yukawa T; Oshitani N; Yamagami H; Watanabe K; Higuchi K; Arakawa T
Int J Mol Med; 2007 Aug; 20(2):161-7. PubMed ID: 17611633
[TBL] [Abstract][Full Text] [Related]
15. The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn's disease.
Cucino C; Sonnenberg A
Am J Gastroenterol; 2001 Jul; 96(7):2107-12. PubMed ID: 11467640
[TBL] [Abstract][Full Text] [Related]
16. Paediatric inflammatory bowel disease in New Zealand.
Yap J; Wesley A; Mouat S; Chin S
N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers.
Devani M; Cugno M; Vecchi M; Ferrero S; Di Berardino F; Avesani EC; de Franchis R; Colman RW
Am J Gastroenterol; 2002 Aug; 97(8):2026-32. PubMed ID: 12190172
[TBL] [Abstract][Full Text] [Related]
18. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
[TBL] [Abstract][Full Text] [Related]
19. Differential responses of VIPergic and nitrergic neurons in paediatric patients with Crohn's disease.
Boyer L; Sidpra D; Jevon G; Buchan AM; Jacobson K
Auton Neurosci; 2007 Jul; 134(1-2):106-14. PubMed ID: 17466601
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).
Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA
Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
